Results 211 to 220 of about 7,352,360 (403)

Non-Viral CRISPR carriers: transient delivery with lasting effects. [PDF]

Drug Deliv
Lummerstorfer M, Lächelt U.
europepmc   +1 more source

Formulation and Evaluation of Sol-Gel Drug Delivery System for Intracanal pH Sensitive Controlled Delivery of Chlorhexidine [PDF]

, 2017
Kapil Gandhi
openalex   +1 more source

Enhancing Oncological Care for India's Aging Population: Addressing the Complex Needs of Older Adults With Cancer

Aging and Cancer, EarlyView.
Aging‐associated physiological and molecular alterations pose significant challenges in cancer management among India's elderly. Limited geriatric oncology expertise, financial constraints, and inadequate specialized care exacerbate disparities. Strategic expansion of insurance coverage, integration of palliative care, and infrastructural advancements ...
Nihanthy D. Sreenath, Mathigatta Shivarudraiah S, Rajath Govind, Kaushik M R   +3 more
wiley   +1 more source

Advances in microneedle Technology for Treatment of retinal degenerative diseases: a narrative review. [PDF]

Biomed Microdevices
Zong Y, Liu J, Yang M, Zhang J, Zou Y, Ye Z, Deng J, Gu W, Du J, Ohno-Matsui K, Kamoi K.   +10 more
europepmc   +1 more source

The Aging Blood: Cellular Origins, Circulating Drivers, and Therapeutic Potential

Aging and Cancer, EarlyView.
As a conduit linking all organs, the blood system both reflects and actively drives systemic aging. This review highlights how circulating pro‐aging and antiaging factors and age‐associated hematopoietic stem cell dysfunction contribute to immunosenescence and multi‐organ decline, positioning the hematopoietic system as a target for aging intervention.
Hanqing He, Jianwei Wang
wiley   +1 more source

A Novel Cell-Penetrating Lipopeptide for DNA Binding, Self-Assembly, and Delivery Into HeLa and Pluripotent Stem Cells. [PDF]

J Pept Sci
de Mello LR, Honda TSB, Castelletto V, Alves PT, Han SW, da Silva ER, Hamley IW.   +6 more
europepmc   +1 more source

Challenges of vaccine presentation and delivery: How can we design vaccines to have optimal programmatic impact?

, 2017
Birgitte Giersing, Anna-Léa Kahn, Courtney Jarrahian, Mercy Mvundura, Carmen Rodriguez, Hiromasa Okayasu, Darin Zehrung   +6 more
openalex   +1 more source

Impact of small MU/segment and dose rate on delivery accuracy of volumetric‐modulated arc therapy (VMAT) [PDF]

, 2016
Long Huang, Tingliang Zhuang, Anthony Mastroianni, T. Djemil, Taoran Cui, Ping Xia   +5 more
openalex   +1 more source

Tracking Motor Progression and Device‐Aided Therapy Eligibility in Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To characterise the progression of motor symptoms and identify eligibility for device‐aided therapies in Parkinson's disease, using both the 5‐2‐1 criteria and a refined clinical definition, while examining differences across genetic subgroups.
David Ledingham, Sahana Sathyanarayana, Charlotte B. Stewart, Robyn Iredale, Victoria Foster, Debra Galley, Mark Baker, Nicola Pavese   +7 more
wiley   +1 more source

The mRNA-Based Innovative Strategy: Progress and Challenges. [PDF]

Nanomicro Lett
Zhou H, Wei D, Chen Z, Chen H, Dong C, Yao W, Wang J, Liu X, Li Y, Yang Y, Tan W.   +10 more
europepmc   +1 more source